Dealmakers at BeiGene, Brii Biosciences and Ideaya Biosciences had a busy end to the year, sharing news of agreements for antibody-drug conjugates (ADCs) and other assets in the final few days of ...

Under the agreement, among other matters, the Company will fully acquire the BRII-179 patents, BRII-179 know-how, and relevant BRII-179 materials, eliminating all future milestones and royalty ...

"This transaction ensures us with uninterrupted clinical supply of BRII-179 and complete ownership of its IP" said Dr. Zhi Hong, Ph.D., Chairman and Chief Executive Officer of Brii Bio. "It vests more ...

A biotechnology firm in Durham is expanding its portfolio with an $18 million deal. STORY HIGHLIGHTS Brii Biosciences acquires BRII-179 assets from VBI Vaccines. The $18 million deal cancels ...

THE SKINNY: “I think what holds this record together is the idea of attachment rather than love,” Sophie Jamieson explains. “The clinical, less romantic nature, the ugly nature, but also the very ...

Several combination treatment studies containing BRII-179 have quickly started to carry forward the Company’s strategy for HBV functional cure “This transaction ensures us with uninterrupted clinical ...

Thursday’s Insider Report: Billionaire Jimmy Pattison invests $13-million in this stock ...

Get notified when new properties matching your search criteria are listed on Allhomes ...